Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of HROWL will decline by -5.75% over the next 2 Weeks and hit $23.94 by Friday, November 24, 2023. In that time frame, HROWL's share price is expected to range between $23.71 and $24.15.
BearishAverageBullishHROWL shares rose +0.28% in Friday, August 8, 2025's trading session, rising from a previous close of $25.33 to move at $25.40. The stock demonstrated notable intraday movement (see HROWL's key stats for a full breakdown), fluctuating between $25.32 and $25.47, a +0.59% trading range. While recent weeks have seen some volatility, HROWL has managed to secure a +0.12% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 14.41K shares changing hands, 10.96K more than the previous session. This amounted to $365.91K in total market activity.
Will HROWL Continue Its Downward Trend?
According to analyst ratings and projections for HROWL, Harrow Health, Inc. 8.625% Senior Notes due 2026 shares are anticipated to decrease by -5.10%, potentially reaching $24.17 per share by November 24, 2023. Short-term technical indicators currently suggest a neutral sentiment for HROWL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the HROWL stock forecast, now is not the best time to buy HROWL stock because its current trading price is +6.10% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on HROWL covering social and institutional perspectives.
HROWL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into HROWL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 51.22% to 53.00%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.90%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.87%, maintains a neutral outlook for the long term. Insights into HROWL's shareholder base show how institutional investors are positioning themselves during these momentum shifts